19 June 2018 : Case report
Unusual Sites of High-Grade Neuroendocrine Carcinomas: A Case Series and Review of the Literature
Unusual clinical course, Unusual setting of medical care, Educational Purpose (only if useful for a systematic review or synthesis)
Geoffrey A. Watson1E*, Yasar Ahmed1F, Sarah Picardo1F, Sonya Chew1F, Shona Cobbe2E, Cillian Mahony2EF, James Crotty3B, Fintan Wallis3B, Martin J. Shelly3B, Patrick Kiely3B, Olu Bunmi Ipadeola4B, Vourneen Healy4B, Nemer Osman1E, Rajnish K. Gupta12EFDOI: 10.12659/AJCR.908953
Am J Case Rep 2018; 19:710-723
Abstract
BACKGROUND: Neuroendocrine tumors (NETs) encompass a diverse group of varying clinicopathological entities arising from cells of the endocrine and nervous systems. The presentation of these unique tumors can range from occult disease discovered incidentally to hyperactive, metastatic secretory tumors. NETs most commonly originate in the gastrointestinal and respiratory tract, although they may occur at any site in the body due to the wide distribution of neuroendocrine cells. Their classification system is complex and continues to evolve, and the current system uses histological grade in defining these subtypes. Neuroendocrine carcinomas (NECs), or high-grade, poorly-differentiated NETs, are the most aggressive subtype. Surgical resection remains the primary treatment modality and may be curative, thus early diagnosis is paramount. Management of advanced NETs remains both a diagnostic and therapeutic challenge; however, advances in our understanding of these unique neoplasms as well as an evolving classification system has led to the development of adjunctive therapeutic approaches aimed to minimize morbidity and improve patient outcomes.
CASE REPORT: We present 6 cases of unusual sites of high-grade neuroendocrine carcinomas involving the cervix, gallbladder, oesophagus, ovary, prostate, and urinary bladder.
CONCLUSIONS: Our case series highlights the heterogenous and aggressive nature of this subtype of NETs as well as their diagnostic and therapeutic difficulties. We also review the evolution of the NET classification system and its impact on the management of these malignancies.
Keywords: Carcinoma, Neuroendocrine, Carcinoma, Small Cell, Receptors, Somatostatin
In Press
21 Mar 2024 : Case report
Chlamydia psittaci Pneumonia: Diagnosis, Treatment, and Challenges in the Context of COVID-19Am J Case Rep In Press; DOI: 10.12659/AJCR.942921
22 Mar 2024 : Case report
Sleep Disorders and Traffic Accidents: Unveiling the Hidden RisksAm J Case Rep In Press; DOI: 10.12659/AJCR.943346
24 Mar 2024 : Case report
Uncommon Combination of Hemoglobin Jax and Hemoglobin Constant Spring Leading to Microcytic AnemiaAm J Case Rep In Press; DOI: 10.12659/AJCR.943560
26 Mar 2024 : Case report
Intrabiliary Rupture of a Hepatic Hydatid Cyst: A Case ReportAm J Case Rep In Press; DOI: 10.12659/AJCR.943893
Most Viewed Current Articles
07 Mar 2024 : Case report
Neurocysticercosis Presenting as Migraine in the United StatesDOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
10 Jan 2022 : Case report
A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV...DOI :10.12659/AJCR.935263
Am J Case Rep 2022; 23:e935263
19 Jul 2022 : Case report
Atlantoaxial Subluxation Secondary to SARS-CoV-2 Infection: A Rare Orthopedic Complication from COVID-19DOI :10.12659/AJCR.936128
Am J Case Rep 2022; 23:e936128
23 Feb 2022 : Case report
Penile Necrosis Associated with Local Intravenous Injection of CocaineDOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250